These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9045916)

  • 1. Reduced susceptibility to Fas-mediated apoptosis in B-1 cells.
    Masuda K; Wang J; Watanabe T
    Eur J Immunol; 1997 Feb; 27(2):449-55. PubMed ID: 9045916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of Fas antigen on activated murine B cells.
    Wang J; Taniuchi I; Maekawa Y; Howard M; Cooper MD; Watanabe T
    Eur J Immunol; 1996 Jan; 26(1):92-6. PubMed ID: 8566089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
    Weintraub JP; Eisenberg RA; Cohen PL
    J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.
    Zhang X; Li L; Choe J; Krajewski S; Reed JC; Thompson C; Choi YS
    Cell Immunol; 1996 Oct; 173(1):149-54. PubMed ID: 8871610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S; Yap D; Knox KA
    Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death.
    Acosta-Rodríguez EV; Craxton A; Hendricks DW; Merino MC; Montes CL; Clark EA; Gruppi A
    Eur J Immunol; 2007 Apr; 37(4):990-1000. PubMed ID: 17357108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.
    Rothstein TL; Wang JK; Panka DJ; Foote LC; Wang Z; Stanger B; Cui H; Ju ST; Marshak-Rothstein A
    Nature; 1995 Mar; 374(6518):163-5. PubMed ID: 7533263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation.
    Kozono Y; Kotzin BL; Holers VM
    J Immunol; 1996 Jun; 156(11):4498-503. PubMed ID: 8666826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular factors that regulate the differentiation and apoptosis of germinal center B cells. Anti-Ig down-regulates Fas expression of CD40 ligand-stimulated germinal center B cells and inhibits Fas-mediated apoptosis.
    Choe J; Kim HS; Zhang X; Armitage RJ; Choi YS
    J Immunol; 1996 Aug; 157(3):1006-16. PubMed ID: 8757604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of thymic B cells by signals of CD40 molecules plus interleukin-10.
    Inaba M; Inaba K; Fukuba Y; Mori S; Haruna H; Doi H; Adachi Y; Iwai H; Hosaka N; Hisha H
    Eur J Immunol; 1995 May; 25(5):1244-8. PubMed ID: 7539753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.
    Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS
    Cell Immunol; 1997 Aug; 179(2):126-37. PubMed ID: 9268496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice.
    Wither JE; Roy V; Brennan LA
    Clin Immunol; 2000 Jan; 94(1):51-63. PubMed ID: 10607490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis.
    Wang Z; Karras JG; Colarusso TP; Foote LC; Rothstein TL
    Cell Immunol; 1997 Sep; 180(2):162-7. PubMed ID: 9341746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
    Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
    J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-x protects primary B cells against Fas-mediated apoptosis.
    Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
    J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas (CD95, APO-1) antigen expression and function in murine mast cells.
    Hartmann K; Wagelie-Steffen AL; von Stebut E; Metcalfe DD
    J Immunol; 1997 Oct; 159(8):4006-14. PubMed ID: 9378990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
    Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
    J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor.
    Tucek-Szabo CL; Andjelić S; Lacy E; Elkon KB; Nikolić-Zugić J
    J Immunol; 1996 Jan; 156(1):192-200. PubMed ID: 8598462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.